Table 1. Patient characteristics, echocardiography parameters and laboratory findings at baseline.
| Variables | Control n = 30 | STEMI n = 72 | p value |
|---|---|---|---|
| Age (years) | 59.8 ± 10.4 | 61.3 ± 14.4 | 0.6052 |
| Male (%) | 76.7 | 81.9 | 0.5407 |
| Systolic blood pressure (mmHg) | 129.8 ± 13.6 | 133.9 ± 17.5 | 0.2603 |
| Diastolic blood pressure (mmHg) | 75.0 ± 7.4 | 77.0 ± 13.2 | 0.4269 |
| Heart rates (beats/min) | 70.4 ± 8.8 | 82.4 ± 12.5 | <0.0001 |
| Diabetes mellitus (%) | 23.3 | 22.2 | 0.9026 |
| Hypertension (%) | 70.0 | 63.9 | 0.5536 |
| Hypercholesterolemia (%) | 50.0 | 59.7 | 0.3663 |
| Active smoker (%) | 36.7 | 54.2 | 0.1072 |
| β-blocker usage (%) | 10.0 | 6.9 | 0.6010 |
| Hs-CRP (mg/l) | 1.68 ± 2.09 | 19.15 ± 23.45 | 0.0002 |
| Creatinine (μmol/l) | 101.4 ± 23.3 | 95.9 ± 16.1 | 0.1704 |
| Fasting glucose (mmol/l) | 5.1 ± 1.7 | 6.6 ± 2.4 | 0.0031 |
| Total cholesterol (mmol/l) | 4.7 ± 1.1 | 4.8 ± 1.1 | 0.7982 |
| LDL cholesterol (mmol/l) | 3.1 ± 1.0 | 3.1 ± 0.8 | 0.8215 |
| LVEDD | 50.0 ± 3.6 | 49.7 ± 4.9 | 0.7605 |
| EF (%) | 69.8 ± 4.8 | 52.6 ± 10.0 | <0.0001 |
| IVS | 9.8 ± 0.7 | 9.7 ± 1.2 | 0.6085 |
| LVPW | 9.6 ± 0.7 | 9.7 ± 1.1 | 0.6349 |
| E | 87.8 ± 7.2 | 81.0 ± 10.5 | 0.0018 |
| A | 89.3 ± 10.6 | 82.6 ± 9.9 | 0.0041 |
| E' | 10.2 ± 2.3 | 8.7 ± 2.0 | 0.0011 |
| E/A | 1.0 ± 0.2 | 1.0 ± 0.2 | 0.9431 |
| E/E' | 8.8 ± 1.3 | 9.5 ± 1.2 | 0.0134 |
Values represent mean ± SD or the percentage of patients.
Hs-CRP, high-sensitivity C-reactive protein; LDL, low-density lipoprotein. LVEDD, left ventricular end-diastolic dimension; EF, ejection fraction; IVS, Interventricular septal end diastolic dimension; LVPW, left ventricular posterior wall thickness; E, peak early diastolic mitral flow velocity; A, peak late diastolic mitral flow velocity; E’, doppler-derived peak early diastolic mitral flow velocity.